Trial participants are followed for up to 14 months and assessed by changes in their motor and non-motor symptoms for 52 weeks of treatment.
Article source: Fox Trial Finder – The Michael J Fox Foundation Trial 4920
We are sorry that this content was not useful for you
Let us improve this content
Can you tell us how we can improve this content?